JTC share price slips as SocGen flags 8.9% stake in Permira takeover trade
19 January 2026
1 min read

JTC share price slips as SocGen flags 8.9% stake in Permira takeover trade

London, Jan 19, 2026, 10:57 GMT — Regular session

Shares of JTC Plc slipped on Monday following Societe Generale’s reveal of an 8.87% stake in the company. That includes a 2.61% position held through a cash-settled equity-linked swap set to expire on Feb. 23. By 1057 GMT, the stock had dipped about 0.2% to 1,290 pence, fluctuating narrowly between 1,290 and 1,292 on volume near 106,000 shares. 1

The slight uptick occurs as JTC remains under a recommended all-cash takeover bid. Papilio Bidco has committed to 1,340 pence per share, placing JTC’s equity value near £2.3 billion and pushing the enterprise value to roughly £2.7 billion, the companies announced back in November. 2

JTC announced on Jan. 15 that shareholders have signed off on the scheme at both court and general meetings. Competition approvals in Austria, the U.S., and Germany are now in place. The company still aims for the deal to close in Q3 2026, pending the final conditions. 3

Deutsche Bank AG London revealed in a separate Takeover Code filing on Monday that it sold 21,171 JTC shares on Jan. 16, with prices ranging from £12.90 to £12.94. The document also confirmed Deutsche Numis is serving as joint financial adviser and broker to JTC. 4

The Form 8.5 disclosure is a standard notice required during an “offer period” under Britain’s Takeover Code. It details trading by banks serving as recognised intermediaries and usually appears daily while a deal is underway.

Investors are focused on the spread. JTC’s shares remain roughly 3.7% under the 1,340p offer price, a gap driven mainly by timing and the slight chance that completion could be delayed.

The SocGen filing comes as a TR-1 notice, the UK’s usual method for reporting significant holdings and some financial instruments. Cash-settled swaps offer economic exposure to a stock but don’t involve transferring the actual shares.

These trades aren’t straightforward. Any delay in the court process or shifts in remaining conditions can leave the stock stuck below the bid. Takeover spreads often widen fast once the market stops viewing the timeline as set in stone.

Traders will keep a close eye on daily disclosures for any changes in positions held by intermediaries and arbitrage funds, particularly if the stock begins to stray from the offer price.

Next on the agenda is the court timetable. The scheme document pins the long-stop date at Nov. 10, 2026, with the sanction hearing slated for Q3 2026. JTC is required to announce the hearing date at least 14 days beforehand. 5

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Melrose Industries share price dips after fresh buyback filing as tariff jitters hit London stocks
Previous Story

Melrose Industries share price dips after fresh buyback filing as tariff jitters hit London stocks

BT share price today: BT Group stock climbs as Openreach widens copper switch push
Next Story

BT share price today: BT Group stock climbs as Openreach widens copper switch push

Go toTop